Cart is empty The risk of fragility fractures is increased in people with both type 1 and type 2 diabetes. While guidance for the evaluation and management of fracture risk in these patients has been recently proposed by an International Osteoporosis Foundation (IOF) working group, a new review now examines a range of biochemical markers, and considers their potential role in helping clinicians further evaluate fracture risk.
Leave A Comment